Latest Period
Q1 2026
Security Snapshot
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) Institutional Ownership
CUSIP: 03969T109
13F Institutional Holders and Ownership History from Q2 2019 to Q1 2026
Institutions Reporting
124
Shares (Excl. Options)
24,289,393
Price
$7.72
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ARCT on Nasdaq
- Shares outstanding
- 28,423,877
- Reported price per share
- $8.26
- Price from insider filings
- $8.26
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 24,289,393
- Total reported value
- $187,312,969
- Portfolio coverage rank
- 0%
- Share change
- +417,054
- Value change
- +$4,939,015
- Number of holders
- 124
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock is tracked under CUSIP 03969T109.
- 124 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 115 to 124 between Q4 2025 and Q1 2026.
- Reported value moved from $144,903,316 to $187,312,969.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 124 institutions filings for Q1 2026.
Security key
03969T109
Latest holder period
Q1 2026
13F holders
124
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
ARCT full holder history
Arcturus Therapeutics Holdings Inc. SEC filings
Arcturus Therapeutics Holdings Inc. company facts
Arcturus Therapeutics Holdings Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03969T109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
ARCT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 12% | $20,250,983 | 3,303,640 | Federated Hermes, Inc. | 31 Dec 2025 | |||
| ARK Investment Management LLC | 10% | +13% | $25,054,226 | +$2,859,884 | 2,947,556 | +13% | ARK Investment Management LLC | 30 Apr 2026 |
| BlackRock, Inc. | 7.8% | $27,169,573 | 2,104,537 | BlackRock, Inc. | 31 Mar 2025 | |||
| Amova Asset Management Americas, Inc. | 7.2% | +1.4% | $35,898,599 | +$400,871 | 1,947,835 | +1.1% | Amova Asset Management Americas, Inc. | 30 Sep 2025 |
| Sumitomo Mitsui Trust Group, Inc. | 7.2% | +1.4% | $35,898,599 | +$400,871 | 1,947,835 | +1.1% | Sumitomo Mitsui Trust Group, Inc. | 30 Sep 2025 |
| STATE STREET CORP | 4.9% | $17,120,700 | 1,326,158 | STATE STREET CORPORATION | 31 Dec 2024 |
As of 31 Mar 2026, 124 institutional investors reported holding 24,289,393 shares of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT). This represents 85% of the company’s total 28,423,877 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
76%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 12% | 3,303,640 | 0% | 0.04% | $25,504,101 |
| ARK Investment Management LLC | 9.7% | 2,769,518 | +6.1% | 0.17% | $21,380,678 |
| BlackRock, Inc. | 9.2% | 2,613,281 | -0.24% | 0% | $20,174,530 |
| Sumitomo Mitsui Trust Group, Inc. | 8.1% | 2,288,935 | +13% | 0.01% | $17,670,578 |
| Amova Asset Management Americas, Inc. | 8.1% | 2,288,935 | +13% | 0.25% | $17,647,689 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 1,107,020 | 0% | 0% | $8,546,194 |
| TWO SIGMA INVESTMENTS, LP | 3.8% | 1,081,784 | +98% | 0.01% | $8,351,372 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.4% | 977,922 | 0% | 0% | $7,549,558 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 660,928 | +6.9% | 0% | $5,103,399 |
| STATE STREET CORP | 1.9% | 543,863 | -3.6% | 0% | $4,198,622 |
| MILLENNIUM MANAGEMENT LLC | 1.7% | 478,557 | +57% | 0% | $3,694,460 |
| UBS Group AG | 1.6% | 458,277 | +101% | 0% | $3,537,899 |
| Empire Life Investments Inc. | 1.3% | 383,493 | -7% | 0.18% | $3,010,420 |
| DIMENSIONAL FUND ADVISORS LP | 1% | 288,355 | -41% | 0% | $2,224,501 |
| ACADIAN ASSET MANAGEMENT LLC | 0.99% | 280,500 | -34% | 0% | $2,159,000 |
| Hennion & Walsh Asset Management, Inc. | 0.98% | 279,679 | +16% | 0.07% | $2,159,122 |
| HEARTLAND ADVISORS INC | 0.9% | 256,000 | 0.1% | $1,976,320 | |
| D. E. Shaw & Co., Inc. | 0.89% | 252,034 | +158% | 0% | $1,945,702 |
| NORTHERN TRUST CORP | 0.77% | 219,613 | +9.4% | 0% | $1,695,412 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.76% | 216,500 | +18% | 0% | $1,671,380 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.72% | 204,014 | +173% | 0% | $1,574,988 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.7% | 198,728 | -32% | 0.01% | $1,534,180 |
| GOLDMAN SACHS GROUP INC | 0.7% | 198,681 | -49% | 0% | $1,533,818 |
| JPMORGAN CHASE & CO | 0.7% | 197,815 | -4.1% | 0% | $1,364,925 |
| BNP PARIBAS FINANCIAL MARKETS | 0.69% | 194,860 | 0% | 0% | $1,504,319 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
28
Latest
Q1 2026
Rows shown
1-25 of 28
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 24,289,393 | $187,312,969 | +$4,939,015 | $7.72 | 124 |
| 2025 Q4 | 23,639,769 | $144,903,316 | -$42,289,755 | $6.13 | 115 |
| 2025 Q3 | 25,813,853 | $475,545,761 | +$6,867,024 | $18.43 | 134 |
| 2025 Q2 | 25,723,468 | $335,038,354 | -$6,831,289 | $13.01 | 140 |
| 2025 Q1 | 26,575,062 | $281,454,102 | -$6,198,440 | $10.59 | 141 |
| 2024 Q4 | 26,610,345 | $451,455,958 | +$561,441 | $16.97 | 144 |
| 2024 Q3 | 26,254,849 | $609,261,942 | -$9,219,231 | $23.21 | 163 |
| 2024 Q2 | 26,274,363 | $639,738,709 | -$34,874,203 | $24.35 | 169 |
| 2024 Q1 | 27,205,455 | $918,443,053 | +$63,004,519 | $33.77 | 176 |
| 2023 Q4 | 25,425,877 | $801,644,603 | +$9,906,113 | $31.53 | 165 |
| 2023 Q3 | 25,171,045 | $643,113,548 | +$38,194,974 | $25.55 | 146 |
| 2023 Q2 | 23,633,969 | $677,565,419 | +$11,461,734 | $28.68 | 143 |
| 2023 Q1 | 23,320,944 | $557,885,187 | +$17,248,370 | $23.97 | 124 |
| 2022 Q4 | 22,638,074 | $383,920,663 | +$11,521,684 | $16.96 | 111 |
| 2022 Q3 | 22,166,410 | $328,065,176 | -$1,828,982 | $14.82 | 106 |
| 2022 Q2 | 20,644,930 | $334,480,556 | +$9,251,825 | $15.74 | 116 |
| 2022 Q1 | 21,454,944 | $578,272,039 | +$36,976,142 | $26.96 | 122 |
| 2021 Q4 | 19,955,158 | $736,203,155 | +$29,436,784 | $37.01 | 133 |
| 2021 Q3 | 19,065,552 | $909,015,330 | -$50,289,411 | $47.78 | 150 |
| 2021 Q2 | 20,506,601 | $693,959,237 | +$36,673,317 | $33.84 | 133 |
| 2021 Q1 | 18,787,112 | $775,920,001 | -$48,861,238 | $41.30 | 153 |
| 2020 Q4 | 19,874,000 | $864,074,837 | +$70,349,611 | $43.38 | 131 |
| 2020 Q3 | 18,215,804 | $783,103,294 | +$221,938,988 | $42.90 | 127 |
| 2020 Q2 | 12,949,979 | $605,805,587 | +$388,736,954 | $46.74 | 112 |
| 2020 Q1 | 4,735,510 | $65,692,000 | +$2,316,123 | $13.59 | 53 |